Canada boasts several centers of excellence with a group of internationally renowned investigators that are at the forefront of oncology clinical research. Many of these centers are highly skilled in early phase work and are highly motivated to help fix a system that is in dire need of repair.

Listen as Karen Arts, Director of Business Development at the OICR and chair of the board of directors for the Network of Networks (N2), talks about the steps Canadian organizations have taken to foster collaboration among stakeholder groups, while improving infrastructure and processes to enhance Canada’s clinical research capability and capacity.